Lataa...
The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
Ovarian cancer is the most lethal gynecological malignancy, with an alarmingly poor prognosis attributed to late detection and chemoresistance. Initially, most tumors respond to chemotherapy but eventually relapse due to the development of drug resistance. Currently, there are no biological markers...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3794832/ https://ncbi.nlm.nih.gov/pubmed/24065105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms140919257 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|